Skip to content
PresyoGamot
Menu

Valproic acid price in the Philippines

Quick answer

The DOH reference price for divalproex sodium (sodium valproate + valproic acid) 250 mg tablet is ₱8.88 per tablet (median, June 2024 index); drugstore prices are usually higher. FDA Philippines lists 40 registered valproic acid products (checked 2026-11-05): 1 as unbranded generics and 39 under 31 brand names. It is a prescription (Rx) medicine. Ask the pharmacist for the unbranded generic of the same strength; it is on the FDA VAT-exempt list, so no 12% VAT applies.

FDA-registered: 40 products31 brandsPrescription (Rx)VAT-exempt

Government reference price

Divalproex Sodium (Sodium Valproate + Valproic Acid) 250 mg Tablet₱8.88DOH reference, median per tablet

At the DOH median, 30 tablets cost about ₱266.40, a month at one a day.

DPRI range, DOH DPRI June 2024. What public hospitals pay; drugstore prices are usually higher.

DOH reference prices

Valproic acid: DOH reference prices

5 items in the DOH index; the lowest median is ₱8.88 for divalproex sodium (sodium valproate + valproic acid) 250 mg tablet.

Valproic acid: DOH reference prices
ItemLowest (₱)Median (₱)Highest (₱)Type
Divalproex Sodium (Sodium Valproate + Valproic Acid) 250 mg Tablet₱7.90₱8.88₱11.38DPRI range
Valproic Acid 250 mg MR tablet₱8.88₱8.88₱8.88DPRI range
Valproic Acid 250 mg/5 mL, 120 mL Syrup Bottle₱314.05₱345.46₱618.00DPRI range
Divalproex Sodium (Sodium Valproate + Valproic Acid) 500 mg Tablet₱6.45₱11.38₱14.00DPRI range
Valproic Acid 500 mg tablet₱11.38₱11.38₱11.38DPRI range

Source: DOH Drug Price Reference Index, June 2024. Prices per unit (tablet, vial, bottle) in pesos, VAT included unless the medicine is VAT-exempt. Hospitals and other facilities may price up to 6.8% above the index, except MWP items.

Strengths

Valproic acid by strength

Valproic acid is listed here in 4 strengths; 3 of them (125 mg, 250 mg, 500 mg) have FDA-registered products in the Philippines.

Valproic acid by strength
StrengthDOH median (₱)FDA products
Valproic acid 125 mg–1
Valproic acid 250 mg₱8.8826
Valproic acid 500 mg₱11.3812
Valproic acid 750 mg–not registered

Sources: FDA Philippines registry (2026-11-05), DOH DPRI June 2024.

About valproic acid

Used for

Valproic acid is a seizure medicine. This page follows the US FDA label for valproic acid liquid-filled capsules; the tablets sold here have their own leaflet and doses. The label lists:

  • complex partial seizures, alone or with other seizure medicines, from age 10
  • simple and complex absence seizures
  • several seizure types that include absence seizures, as an add-on

How it works

In the gut it turns into valproate. The label says the exact way it works is not proven; its effect on epilepsy may be linked to higher levels of GABA, a calming chemical in the brain.

How to take it and usual dose

Swallow the capsules whole without chewing, every day as prescribed. The dose depends on body weight. Treatment usually starts at 10 to 15 mg per kg a day and is raised each week by 5 to 10 mg per kg until seizures are controlled. Good control is usually reached below 60 mg per kg a day. If you miss a dose, take it soon unless the next one is near, and never double up. Your doctor decides the dose.

Do not use if

  • you have liver disease or poor liver function
  • you have a mitochondrial disorder caused by POLG gene changes
  • you have a urea cycle disorder
  • you are allergic to valproic acid
  • for migraine prevention: you are pregnant, or could become pregnant and do not use reliable birth control

The US label carries a boxed warning about life-threatening liver failure and serious birth defects.

Common side effects

Frequent ones are nausea, vomiting, belly pain, diarrhea, sleepiness, dizziness, shaking, hair loss, weight change and blurred or double vision. Get help right away for weakness, face swelling, loss of appetite or vomiting early in treatment, severe belly pain, unusual bleeding or bruising, confusion, or thoughts of self-harm.

Source: US FDA label (DailyMed), 2026-09-21. A summary of the official label, not medical advice: your doctor or pharmacist knows your case.

Registered products

Registered valproic acid products

FDA Philippines lists 40 registrations under 32 brand names (one row is unbranded generics).

Registered valproic acid products
BrandStrength and formClassManufacturerReg.
Akudiva 250 ER250 mg Extended-Release Tablet (equivalent to Divalproex Sodium)RxAkums Drugs & Pharmaceuticals Ltd. (Plant I-Solid Oral Dosage Facility) (India)1
Akudiva 500 ER500 mg Extended-Release Tablet (equivalent to Divalproex Sodium)RxAkums Drugs & Pharmaceuticals Ltd. (Plant I – Solid Oral Dosage Facility) (India)1
Alprosant250 mg/5 mL SyrupRxNovagen Healthcare Private Limited (India)1
Aplop250 mg (equivalent to 288.15 mg sodium valproate)/ 5 mL SyrupRxAzarias Pharmaceutical Laboratories Inc. (Philippines)1
Convulzor250 mg Extended-Release Tablet (equivalent to Divalproex Sodium); 250 mg/5 mL Syrup; 500 mg Extended-Release Tablet (equivalent to Divalproex Sodium)RxAkums Drugs & Pharmaceuticals Ltd. (Plant I – Solid Oral Dosage Facility) (India) +2 more3
Depakene250mg/5mL SyrupRxP.T. Abbott Indonesia (Indonesia)2
Depakote ER1 g Extended Release Tablet; 250 mg Extended Release Tablet; 500 mg Extended -Release TabletRxAbbott Laboratorios Do Brasil LTDA (Brazil) +2 more3
DepakoteDepakote125mg Sprinkle CapsuleRxAbbVie Inc. (United Kingdom)1
Show 24 more brands

Registered valproic acid products, continued

Registered valproic acid products, continued
BrandStrength and formClassManufacturerReg.
Depamax250 mg Extended-Release Tablet (equivalent to Divalproex Sodium); 250 mg/ 5 mL Syrup; 500 mg Extended-Release Tablet (equivalent to Divalproex Sodium)RxAkums Drugs & Pharmaceuticals Ltd. (Plant I – Solid Oral Dosage Facility) (India) +2 more3
Diaprax500 mg Extended-Release TabletRxBaroque Pharmaceuticals Pvt. Ltd (India)1
Dicorate ER 500500 mg Extended-Release TabletRxSun Pharmaceutical Industries Ltd. (India)1
Divalfred500 mg Extended-Release TabletRxFredun Pharmaceuticals Limited (India)1
Divalgen 250250 mg Extended-Release Tablet (equivalent to Divalproex Sodium)RxAkums Drugs & Pharmaceuticals Ltd. (Plant I-Solid Oral Dosage Facility) (India)1
Divalgen 500500 mg Extended-Release Tablet (equivalent to Divalproex Sodium)RxAkums Drugs & Pharmaceuticals Ltd. (Plant I – Solid Oral Dosage Facility) (India)1
Divoex250 mg Extended-Release Tablet; 500 mg Extended-Release TabletRxRavian Life Science Pvt. Ltd. (India)2
Encorate250 mg/5 mL SyrupRxPT Ferron Par Pharmaceuticals (Indonesia)1
Epival250 mg Enteric-Coated TabletRxPT Abbott Indonesia (Indonesia)1
LEPSIO250 MG/ 5ML SYRUPRx–1
Lepsodex ER250 mg Extended Release TabletRxPT Dexa Medica (Indonesia)1
Neurovalex 250250 mg Extended-Release TabletRxRavian Life Science Pvt. Ltd. (India)1
Neurovalex 500500 mg Extended-Release TabletRxRavian Life Science Pvt. Ltd. (India)1
Prolic250 mg (equivalent to 288.15 mg sodium valproate)/ 5 mL SyrupRxAzarias Pharmaceutical Laboratories Inc. (Philippines)1
Saphvalproex500 mg Extended-Release TabletRxGenom Biotech Pvt. Ltd. (India)1
Valpogen250 mg (equivalent to 288.15 mg sodium valproate)/ 5 mL SyrupRxAzarias Pharmaceutical Laboratories Inc. (Philippines)1
Valprex250 mg/5 mL SyrupRxMercury Laboratories Ltd. (India)1
Valpricid500 mg Extended-Release Tablet (equivalent to Divalproex Sodium)RxAkums Drugs & Pharmaceuticals Ltd. (Plant I – Solid Oral Dosage Facility) (India)1
Valprodin250 mg/5 mL SyrupRxSydenham Laboratories, Inc. (Philippines)1
Valpros Pedia250 mg / 5 mL Syrup (Cherry Flavor)RxPT. Darya-Varia Laboratoria TBK (Indonesia)1
Valprox250 mg/5 mL SyrupRxKwality Pharmaceuticals Ltd. (India)1
Valtor250 mg / 5mL SyrupRxPT Ferron Par Pharmaceuticals (Indonesia)1
ZYSTAL250 mg Film-Coated TabletRxHansel Pharmaceuticals (Pvt.) Ltd (Pakistan)1
No brand (generic)250 mg/5 mL SyrupRxNovagen Healthcare Private Limited. (India)1

Source: FDA Philippines product registry, checked 2026-11-05. Look up any registration number at verification.fda.gov.ph.

Official leaflets

The package insert (PI) and patient leaflet (PIL) filed with FDA Philippines. Doses, side effects and warnings are there, written by the maker and approved by FDA.

Paying less for valproic acid

  • Ask for the generic

    Prescriptions are written in generic names, and the pharmacist must tell you every brand of that generic and its price. How it works

  • Senior or PWD card

    20% off plus no VAT on your own medicines, with ID and prescription. What to bring

  • No VAT on this one

    It is on the FDA VAT-exempt list, so the 12% VAT should not be on your receipt. The list

Questions people ask

Do I need a prescription for valproic acid in the Philippines?

FDA Philippines classifies valproic acid as a prescription (Rx) medicine. A pharmacist may dispense it only against a valid prescription (Pharmacy Act, RA 10918).

Is there a generic valproic acid registered in the Philippines?

FDA Philippines lists 40 registered valproic acid products (checked 2026-11-05): 1 sold under the generic name only and 39 under 31 brand names. Ask the pharmacist for the unbranded generic: same ingredient and strength.

How much does valproic acid cost in the Philippines?

The DOH Drug Price Reference Index, June 2024 edition, lists divalproex sodium (sodium valproate + valproic acid) 250 mg tablet at a median of ₱8.88 (range ₱7.90 to ₱11.38). That is what public hospitals pay; drugstore prices are usually higher.

Where can I buy valproic acid legally?

From an FDA-licensed drugstore or botika; the licence to operate (LTO) should be displayed in the store. Bring your prescription. Check that the box carries a DR- registration number, and be careful with online sellers that are not licensed pharmacies.

Is valproic acid over the counter in the Philippines?

No. FDA Philippines lists all registered valproic acid products, including syrups and extended-release tablets, as prescription (Rx) drugs.

Is valproic acid safe in pregnancy?

The label warns it can cause major birth defects and should not be used in pregnancy unless other medicines have failed.

Data: FDA Philippines registry (checked 2026-11-05), DOH Drug Price Reference Index (June 2024). Sources and method.